HPV16 and increased risk of recurrence after treatment for CIN

This publication has 19 references indexed in Scilit:

• Clinical utility of HPV–DNA detection: Triage of minor cervical lesions, follow-up of women treated for high-grade CIN: An update of pooled evidence
  Gynecologic Oncology, 2005
• Prevalence of types 16 and 33 is increased in high‐risk human papillomavirus positive women with cervical intraepithelial neoplasia grade 2 or worse
  International Journal of Cancer, 2005
• HPV Testing and Monitoring of Women After Treatment of CIN 3: Review of the Literature and Meta-analysis
  Obstetrical & Gynecological Survey, 2004
• The presence of high‐risk HPV combined with specific p53 and p16^INK4a expression patterns points to high‐risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix
  The Journal of Pathology, 2003
• Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia
  British Journal of Cancer, 2001
• Relation of human papilloma virus status to cervical lesions and consequences for cervical-cancer screening: a prospective study
  The Lancet, 1999
• A randomized clinical trial of cryotherapy, laser vaporization, and loop electrosurgical excision for treatment of squamous intraepithelial lesions of the cervix
  Obstetrics & Gynecology, 1998
• Natural History of Cervicovaginal Papillomavirus Infection in Young Women
  New England Journal of Medicine, 1998
• Human Papillomavirus Analysis as a Prognostic Marker Following Conization of the Cervix Uteri
  Gynecologic Oncology, 1997
• Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens
  American Journal of Obstetrics and Gynecology, 1996